ITOTvsPBE
iShares Core S&P Total U.S. Stock Market ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| ITOT | PBE | |
|---|---|---|
| Expense ratio | 0.030% | 0.58% |
| Assets | $96.6B | $398M |
| Net flow, 1 month | −$817M | +$90M |
| Net flow, 1 year | +$7.1B | +$88M |
| Return, YTD | +12.6% | +18.5% |
| Return, 1 year | +18.9% | +41.8% |
| Avg daily volume | 1.5M | 52K |
| Holdings | 2523 | 31 |
| Listed | Jan 19, 2004 | Jun 22, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS